NielsenIQ Sets the Pace for the Omnichannel Measurement Revolution
28.9.2021 15:00:00 EEST | Business Wire | Press release
NielsenIQ, the industry leader in global measurement and data analytics, announced today two key acquisition agreements --Data Impact and Rakuten Intelligence. These acquisitions will drive significant value to NielsenIQ’s e-commerce and omnichannel measurement solutions and allow the company to revolutionize the consumer and retail measurement industries with a comprehensive view of the online marketplace, from product distribution to sales.
Today, e-commerce sales account for 12% of CPG sales in the U.S. and up to 30% of sales in global markets and are estimated to grow at a 15% CAGR through 2025. With significant growth and share from online-focused retailers, it has become more important to understand the total marketplace. Nevertheless, current e-commerce measurement is highly fragmented, with multiple, disparate offerings that do not allow an integrated and consistent view of the total market.
These acquisitions and suite of omnichannel measurement solutions uniquely position NielsenIQ to provide retailers and manufacturers with a harmonized, granular, and consistent view across channels, allowing them to anticipate trends, understand, and react faster to consumer needs and expectations.
“Measuring e-commerce is a top strategic imperative for NielsenIQ,” said Natalie Williams, Head of North America Measurement Product Leadership, NielsenIQ. “Together we can transform the way we measure e-commerce sales and how fast the shopper journey evolves by delivering powerful machine learning-driven insights to our clients around the world.”
The agreement to acquire Data Impact, a leading e-commerce intelligence player in 40 markets mainly across Europe and the U.S., will supercharge NielsenIQ’s omnichannel service. Combining Data Impact’s best-in-class technology - which provides a hypergranular view of banner and store-level e-commerce insights - with NielsenIQ’s unmatched retail measurement footprint, will enable NielsenIQ to scale Data Impact’s product offering globally; and most importantly, will position NielsenIQ to lead the future of omnichannel measurement and execution.
“Combining our technology with Data Impact’s unique offering enables us to offer manufacturers and retailers unparalleled, comprehensive coverage with the granularity needed to make winning omnichannel decisions,” said Jim Peck, Executive Chairman and CEO of NielsenIQ.
The acquisition of Rakuten Intelligence, three years after signing an exclusive agreement to combine Rakuten Intelligence’s largest e-commerce purchase panel in the U.S. with NielsenIQ’s retail sales data, will allow NielsenIQ to deliver our clients an integrated online and offline read, aligned to custom client hierarchies, underpinned by our cloud-based Connect platform. NielsenIQ’s recently launched Omnisales product is the first integration derived from this acquisition.
“We are proud to welcome these two champions into the NielsenIQ family. We will be able to provide a single number for online sales measurement through multi-sourced data - the truth the market needs - and we will also deliver e-commerce execution recommendations with unrivaled actionability. With unique scale and granularity, the landscape of opportunities is unlimited,” mentioned Clément Colin, Head of International E-commerce Measurement, NielsenIQ.
About NielsenIQ
NielsenIQ is the leader in providing the most complete, unbiased view of consumer behavior, globally. Powered by a groundbreaking consumer data platform and fueled by rich analytic capabilities, NielsenIQ enables bold, confident decision-making for the world’s leading consumer goods companies and retailers.
Using comprehensive data sets and measuring all transactions equally, NielsenIQ gives clients a forward-looking view into consumer behavior in order to optimize performance across all retail platforms. Our open philosophy on data integration enables the most influential consumer data sets on the planet. NielsenIQ delivers the complete truth.
NielsenIQ, an Advent International portfolio company, has operations in nearly 100 markets, covering more than 90% of the world’s population. For more information, visit NielsenIQ.com.
About Data Impact
Data Impact is one of the cutting-edge providers in omnichannel analytics solutions. The company uses localized data and AI algorithms to offer its customers various solutions, including location-based analytics, sales and shares estimates, media monitoring, SEO optimization, and more.
The Data Impact solution is already used by more than 150 companies in more than 40 countries. Launched in 2016, Data Impact is the only solution that offers FMCG manufacturers a precise visualization of their omnichannel distribution and the ability to identify localized levers of action.
About Rakuten Intelligence
Rakuten Intelligence is part of Rakuten Advertising, which connects leading agencies, brands and publishers to active and engaged consumers around the world. With access to Rakuten’s diverse media properties and audiences, combined with an award-winning performance network and proprietary consumer research, Rakuten Advertising creates the right conditions to reach new customers and sustain long-lasting loyalty.
Its foundation of advanced technology, data, and strategic services positions Rakuten Advertising to offer a differentiated suite of marketing and advertising solutions while continually pushing the industry forward. It is a division of Rakuten Inc., one of the world’s leading Internet service companies. The company is headquartered in San Mateo, CA, with offices throughout EMEA, APAC, LATAM, and North America. Learn more at www.rakutenadvertising.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210928005136/en/
Contact information
Media Relations:
(U.S. and English)
FERNANDA PAREDES, fernanda.paredes@nielseniq.com, +1-917-291-1196
GILLIAN MOSHER, gillian.mosher@nielseniq.com, +1-647-282-9714
(France) SEBASTIEN MONARD, sebastien.monard@nielseniq.com, +33-6-85-32-94-61
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
